Khare S, Bissonnette M, Wali R, Skarosi S, Boss G R, von Lintig F C, Scaglione-Sewell B, Sitrin M D, Brasitus T A
Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA.
Am J Physiol. 1999 Apr;276(4 Pt 1):G1005-15. doi: 10.1152/ajpgi.1999.276.4.g1005.
In the accompanying paper [Khare et al., Am. J. Physiol. 276 (Gastrointest. Liver Physiol. 39): G993-G1004, 1999], activation of protein kinase C-alpha (PKC-alpha) was shown to be involved in the stimulation of phospholipase D (PLD) by 1,25-dihydroxyvitamin D3 [1, 25(OH)2D3] and 12-O-tetradecanoylphorbol 13-acetate (TPA) in Caco-2 cells. Monomeric or heterotrimeric G proteins, as well as pp60(c-src) have been implicated in PLD activation. We therefore determined whether these signal transduction elements were involved in PLD stimulation by 1,25(OH)2D3 or TPA. Treatment with C3 transferase, which inhibits members of the Rho family of monomeric G proteins, markedly diminished the ability of 1,25(OH)2D3, but not TPA, to stimulate PLD. Brefeldin A, an inhibitor of ADP-ribosylation factor proteins, did not, however, significantly reduce the stimulation of PLD by either of these agents. Moreover, 1,25(OH)2D3, but not TPA, activated pp60(c-src) and treatment with PP1, a specific inhibitor of the pp60(c-src) family, blocked the ability of 1,25(OH)2D3 to activate PLD. Pretreatment of cells with pertussis toxin (PTx) markedly reduced the stimulation of PLD by either agonist. PTx, moreover, inhibited the stimulation of pp60(c-src) and PKC-alpha by 1,25(OH)2D3. PTx did not, however, block the membrane translocation of RhoA induced by 1,25(OH)2D3 or inhibit the stimulation of PKC-alpha by TPA. These findings, taken together with those of the accompanying paper, indicate that although 1,25(OH)2D3 and TPA each activate PLD in Caco-2 cells in part via PKC-alpha, their stimulation of PLD differs in a number of important aspects, including the requirement for pp60(c-src) and RhoA in the activation of PLD by 1,25(OH)2D3, but not TPA. Moreover, the requirement for different signal transduction elements by 1,25(OH)2D3 and TPA to induce the stimulation of PLD may potentially underlie differences in the physiological effects of these agents in Caco-2 cells.
在随附论文[Khare等人,《美国生理学杂志》276(Gastrointest. Liver Physiol. 39): G993 - G1004, 1999]中,已表明蛋白激酶C-α (PKC-α)的激活参与了1,25 - 二羟基维生素D3 [1, 25(OH)2D3]和12 - O - 十四烷酰佛波醇13 - 乙酸酯(TPA)对Caco - 2细胞中磷脂酶D (PLD)的刺激作用。单体或异源三聚体G蛋白以及pp60(c-src)都与PLD的激活有关。因此,我们确定这些信号转导元件是否参与了1,25(OH)2D3或TPA对PLD的刺激作用。用C3转移酶处理,该酶可抑制单体G蛋白的Rho家族成员,显著降低了1,25(OH)2D3刺激PLD的能力,但不影响TPA刺激PLD的能力。然而,布雷菲德菌素A (一种ADP - 核糖基化因子蛋白的抑制剂)并没有显著降低这两种试剂对PLD的刺激作用。此外,1,25(OH)2D3可激活pp60(c-src),而TPA则不能,用PP1 (pp60(c-src)家族的特异性抑制剂)处理可阻断1,25(OH)2D3激活PLD的能力。用百日咳毒素(PTx)预处理细胞可显著降低两种激动剂对PLD的刺激作用。此外,PTx可抑制1,25(OH)2D3对pp60(c-src)和PKC-α的刺激作用。然而,PTx并不阻断1,25(OH)2D3诱导的RhoA的膜转位,也不抑制TPA对PKC-α的刺激作用。这些发现与随附论文的结果一起表明,尽管1,25(OH)2D3和TPA均部分通过PKC-α在Caco - 2细胞中激活PLD,但它们对PLD的刺激在许多重要方面存在差异,包括1,25(OH)2D3激活PLD需要pp60(c-src)和RhoA,而TPA则不需要。此外,1,25(OH)2D3和TPA诱导PLD刺激所需的不同信号转导元件可能是这些试剂在Caco - 2细胞中生理效应差异的潜在原因。